Current approaches in the treatment of pregnancy miscarriage
Posted by: В.В. Kaminskyi, V.V. Konoplianko, M.N. Shalko, N.Ya. Ratushniak Department of Obstetrics, Gynecology and Reproductology of the NMAPE named after P.L. Shupyk Kyiv City Center for Reproductive and Perinatal Medicine. Publication Place: Reproductive Health. Eastern Europe. 2018, Volume 8, №1. Summary: The article presents the results of the study of the effectiveness of the drug Proginorm OVO and Proginorm GESTA in the schemes of complex therapy of the threat of termination of pregnancy and the threat of premature birth. 290 pregnancies with the risk of interruption or the risk of preterm birth were analyzed at different times. Women groups were representative of age, parity, place of residence, social status, and somatic health status. the efficacy in the treatment regimen of the oral form of natural micronized progesterone Proginorm OVO 100 mg, 200mg and vaginal form Progestin GESTA 100 mg, 200mg with individual selection of therapeutic dose from 200mg to...